In recent years NfL has evolved as a powerful marker of disease severity in neurological disorders, especially in multiple sclerosis and neurodegenerative diseases such as Alzheimer’s disease, but also in acute neurological diseases such as ischemic stroke or traumatic brain injury1–4. The gene discussed is NEFL; the disease is ischemic stroke.